Bleomycin-induced flagellate dermatitis

dc.contributorUniversidade Federal de São Paulo (UNIFESP)
dc.creatorMota, Guilherme Devidé
dc.creatorPenna, Adriana Marques Damasco
dc.creatorSoares, Regina Cláudia
dc.creatorBaiocchi, Otavio Carvalho Guimarães
dc.date.accessioned2015-06-14T13:47:11Z
dc.date.accessioned2019-05-24T17:19:25Z
dc.date.available2015-06-14T13:47:11Z
dc.date.available2019-05-24T17:19:25Z
dc.date.created2015-06-14T13:47:11Z
dc.date.issued2014-07-01
dc.identifierRevista Brasileira de Hematologia e Hemoterapia. Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular, v. 36, n. 4, p. 297-299, 2014.
dc.identifier1516-8484
dc.identifierhttp://repositorio.unifesp.br/handle/11600/8479
dc.identifierS1516-84842014000400297.pdf
dc.identifierS1516-84842014000400297
dc.identifier10.1016/j.bjhh.2014.03.001
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/2827731
dc.description.abstractA 29-year-old woman with stage IVB Hodgkin's lymphoma was treated with doxorubicin, bleomycin, vinblastine, and dacarbazine. Two weeks after the first cycle was completed, she developed pruritic, linear erythematous lesions in a flagellate-like pattern on the trunk, neck and arms. After oral prednisone therapy and cessation of bleomycin, the lesions started to recede.
dc.languageeng
dc.publisherAssociação Brasileira de Hematologia e Hemoterapia e Terapia Celular
dc.relationRevista Brasileira de Hematologia e Hemoterapia
dc.rightsAcesso aberto
dc.subjectBleomycin
dc.subjectDrug eruptions
dc.subjectErythema
dc.titleBleomycin-induced flagellate dermatitis
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución